• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗部分缓解的抑郁症患者功能转归的临床及神经认知预测因素:一年随访研究

Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study.

作者信息

Castellano Sabrina, Torrent Carla, Petralia Maria Cristina, Godos Justyna, Cantarella Rita Anna, Ventimiglia Andrea, De Vivo Simona, Platania Silvia, Guarnera Maria, Pirrone Concetta, Drago Filippo, Vieta Eduard, Di Nuovo Santo, Popovic Dina, Caraci Filippo

机构信息

Department of Educational Sciences, University of Catania, Catania, Italy.

Barcelona Bipolar Disorders Program, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.

出版信息

Neuropsychiatr Dis Treat. 2020 Feb 28;16:589-595. doi: 10.2147/NDT.S224754. eCollection 2020.

DOI:10.2147/NDT.S224754
PMID:32184600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7055477/
Abstract

BACKGROUND

Cognitive dysfunction represents a distinct biological and clinical dimension in major depression disorders (MDD) and cognitive performance strongly affects psychosocial functioning in patients diagnosed with MDD.

OBJECTIVE

To assess which neurocognitive variables at baseline predict the functional outcome of MDD patients in a 1-year follow-up study as assessed by Functioning Assessment Short Test (FAST) and whether the improvement observed on affective and cognitive symptoms in our 12 week-prospective observational study after treatment with selective serotonin reuptake inhibitors (SSRIs) and selective noradrenalin reuptake inhibitors (SNRIs) can affect the following long-term psychosocial functional outcome at 1 year in the same MDD patients.

METHODS

We recruited a total of 31 patients (8 males; 23 females) with MDD who had previously completed a pharmacological treatment with SSRIs (n = 22) or SNRIs (n = 9) for 12 weeks, and then continued the same pharmacological treatment for 1 year. After an average 1-year follow-up, they were interviewed with the FAST to assess functional outcome. Multivariate analyses were applied to identify clinical and neurocognitive predictors of functional outcome.

RESULTS

Total Montreal Cognitive Assessment (MoCA), Digit Span forward (Span F) and backward (Span B), and 15 Rey words immediate recall (Rey I) scores significantly correlated with FAST. However, after performing regression models only Rey immediate recall score was useful to predict long-term functional outcome (Pearson correlation coefficient R= -0.68, p < 0.001) in four specific subdomains of FAST. When considering changes in affective and cognitive symptoms at the end of the 12 weeks of pharmacological treatment with SSRI or SNRIs (T1-T0) by multiple regression analysis, we found that Span -test predicted scores in the FAST leisure domain, whereas, changes in Span F, Frontal Assessment Battery (FAB) and Rey I predicted psychosocial functioning in the specific "cognitive" subdomains of FAST.

CONCLUSION

Our data suggest that long-term psychosocial functioning can be influenced by neurocognitive performance at baseline, with verbal memory playing a key role in overall functioning. Furthermore, improvement in verbal memory can predict functional outcome at one year in MDD patients with a recent history of partial response to antidepressants.

摘要

背景

认知功能障碍是重度抑郁症(MDD)中一个独特的生物学和临床维度,认知表现强烈影响被诊断为MDD患者的心理社会功能。

目的

在一项为期1年的随访研究中,评估哪些基线神经认知变量可预测MDD患者的功能结局(通过功能评估简短测试(FAST)进行评估),以及在我们为期12周的前瞻性观察研究中,经选择性5-羟色胺再摄取抑制剂(SSRI)和选择性去甲肾上腺素再摄取抑制剂(SNRI)治疗后,观察到的情感和认知症状改善是否会影响同一MDD患者1年后的长期心理社会功能结局。

方法

我们共招募了31例MDD患者(8例男性;23例女性),这些患者之前已完成12周的SSRI(n = 22)或SNRI(n = 9)药物治疗,然后继续相同的药物治疗1年。平均随访1年后,用FAST对他们进行访谈以评估功能结局。应用多变量分析来确定功能结局的临床和神经认知预测因素。

结果

蒙特利尔认知评估(MoCA)总分、数字广度顺背(Span F)和倒背(Span B)以及15个雷伊词语即刻回忆(Rey I)得分与FAST显著相关。然而,在进行回归模型分析后,仅雷伊即刻回忆得分可用于预测FAST四个特定子领域的长期功能结局(皮尔逊相关系数R = -0.68,p < 0.001)。当通过多元回归分析考虑在使用SSRI或SNRI进行12周药物治疗结束时(T1 - T0)情感和认知症状的变化时,我们发现Span -测试可预测FAST休闲领域的得分,而Span F、额叶评估量表(FAB)和雷伊I的变化可预测FAST特定“认知”子领域的心理社会功能。

结论

我们的数据表明,长期心理社会功能可能受基线神经认知表现的影响,言语记忆在整体功能中起关键作用。此外,言语记忆的改善可预测近期对抗抑郁药有部分反应史的MDD患者1年后的功能结局。

相似文献

1
Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study.治疗部分缓解的抑郁症患者功能转归的临床及神经认知预测因素:一年随访研究
Neuropsychiatr Dis Treat. 2020 Feb 28;16:589-595. doi: 10.2147/NDT.S224754. eCollection 2020.
2
Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.选择性5-羟色胺再摄取抑制剂及5-羟色胺与去甲肾上腺素再摄取抑制剂可改善部分缓解型抑郁症患者的认知功能:一项前瞻性观察队列研究的结果
CNS Neurol Disord Drug Targets. 2016;15(10):1290-1298. doi: 10.2174/1871527315666161003170312.
3
New Psychometric Strategies for the Evaluation of Affective, Cognitive, and Psychosocial Functioning in Unipolar Bipolar Depression: Impact of Drug Treatment.用于评估单相和双相抑郁症患者情感、认知及心理社会功能的新心理测量策略:药物治疗的影响
CNS Neurol Disord Drug Targets. 2024;23(2):262-270. doi: 10.2174/1568007X04666230313091253.
4
Predictors of functional outcome in patients with major depression and bipolar disorder: A dynamic network approach to identify distinct patterns of interacting symptoms.预测重性抑郁障碍和双相障碍患者的功能结局:一种动态网络方法,以识别相互作用症状的不同模式。
PLoS One. 2023 Feb 15;18(2):e0276822. doi: 10.1371/journal.pone.0276822. eCollection 2023.
5
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.阿立哌唑与安非他酮或选择性5-羟色胺再摄取抑制剂/5-羟色胺-去甲肾上腺素再摄取抑制剂联合使用的比较:一项为期52周的开放标签研究中开始接受辅助治疗患者的分析。
BMC Res Notes. 2014 Jul 18;7:459. doi: 10.1186/1756-0500-7-459.
6
The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis.在重性抑郁障碍患者中,症状与药物治疗的动态相互作用:网络干预分析的作用。
BMC Psychiatry. 2023 Nov 28;23(1):885. doi: 10.1186/s12888-023-05300-y.
7
Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment.文拉法辛/去甲文拉法辛治疗反应不足的重性抑郁障碍患者中伏硫西汀对情感迟钝的疗效。
J Affect Disord. 2021 Mar 15;283:472-479. doi: 10.1016/j.jad.2020.11.106. Epub 2020 Nov 19.
8
Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram.文拉法辛或艾司西酞普兰治疗的抑郁患者血浆脑源性神经营养因子浓度与认知功能的相关性。
Psychopharmacology (Berl). 2021 Jun;238(6):1575-1584. doi: 10.1007/s00213-021-05790-2. Epub 2021 Feb 9.
9
Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.使用回顾性索赔数据分析重度抑郁症中品牌药和仿制药的治疗模式及持续性。
Neuropsychiatr Dis Treat. 2016 Oct 25;12:2755-2764. doi: 10.2147/NDT.S115094. eCollection 2016.
10
Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.文拉法辛与选择性5-羟色胺再摄取抑制剂(SSRI)抗抑郁治疗药物相互转换治疗重度抑郁症的药学及医疗成本。
J Manag Care Pharm. 2008 Jun;14(5):426-41. doi: 10.18553/jmcp.2008.14.5.426.

引用本文的文献

1
Resting-State Alpha Activity in the Frontal and Occipital Lobes and Assessment of Cognitive Impairment in Depression Patients.抑郁症患者额叶和枕叶静息态α活动与认知障碍评估
Psychol Res Behav Manag. 2024 Aug 17;17:2995-3003. doi: 10.2147/PRBM.S459954. eCollection 2024.
2
Aberrant functional connectivity associated with drug response in patients with newly diagnosed epilepsy.与新诊断癫痫患者药物反应相关的异常功能连接。
Neurol Sci. 2024 Oct;45(10):4973-4982. doi: 10.1007/s10072-024-07529-1. Epub 2024 Apr 24.
3
Does Baseline Cognitive Function Predict the Reduction Rate in HDRS-17 Total Scores in First-Episode, Drug-Naïve Patients with Major Depressive Disorder?

本文引用的文献

1
Executive Function and Spatial Cognition Mediate Psychosocial Dysfunction in Major Depressive Disorder.执行功能和空间认知介导重度抑郁症中的心理社会功能障碍。
Front Psychiatry. 2018 Oct 29;9:539. doi: 10.3389/fpsyt.2018.00539. eCollection 2018.
2
The role of cognitive impairment in psychosocial functioning in remitted depression.认知障碍在缓解期抑郁症的社会心理功能中的作用。
J Affect Disord. 2018 Aug 1;235:129-134. doi: 10.1016/j.jad.2018.04.051. Epub 2018 Apr 6.
3
The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study.
基线认知功能能否预测首发、未用过药物的重度抑郁症患者汉密尔顿抑郁量表-17项总分的降低率?
Neuropsychiatr Dis Treat. 2024 Feb 23;20:353-361. doi: 10.2147/NDT.S453447. eCollection 2024.
4
The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis.在重性抑郁障碍患者中,症状与药物治疗的动态相互作用:网络干预分析的作用。
BMC Psychiatry. 2023 Nov 28;23(1):885. doi: 10.1186/s12888-023-05300-y.
5
If you feel you can't, you won't: the role of subjective and objective cognitive competence on psychosocial functioning in depression.如果你觉得自己不行,你就真的不行:主观和客观认知能力在抑郁症的心理社会功能中的作用。
Eur Psychiatry. 2023 Oct 19;66(1):e83. doi: 10.1192/j.eurpsy.2023.2454.
6
Predictors of functional outcome in patients with major depression and bipolar disorder: A dynamic network approach to identify distinct patterns of interacting symptoms.预测重性抑郁障碍和双相障碍患者的功能结局:一种动态网络方法,以识别相互作用症状的不同模式。
PLoS One. 2023 Feb 15;18(2):e0276822. doi: 10.1371/journal.pone.0276822. eCollection 2023.
7
Real-World Functioning in Psychiatric Outpatients: Predictive Factors.精神科门诊患者的现实世界功能:预测因素。
J Clin Med. 2022 Jul 28;11(15):4400. doi: 10.3390/jcm11154400.
8
Cognition in Recent Suicide Attempts: Altered Executive Function.近期自杀未遂者的认知:执行功能改变
Front Psychiatry. 2021 Jul 22;12:701140. doi: 10.3389/fpsyt.2021.701140. eCollection 2021.
文拉法辛对伴发抑郁障碍的工作患者认知表现的影响:一项短期、随机、双盲、探索性研究。
J Affect Disord. 2018 Mar 15;229:421-428. doi: 10.1016/j.jad.2017.12.056. Epub 2017 Dec 28.
4
Vortioxetine: A new alternative for the treatment of major depressive disorder.伏硫西汀:治疗重度抑郁症的一种新选择。
Rev Psiquiatr Salud Ment (Engl Ed). 2018 Jan-Mar;11(1):48-59. doi: 10.1016/j.rpsm.2017.06.006. Epub 2017 Aug 8.
5
Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives.单相抑郁症神经认知症状的治疗:系统评价与未来展望
J Affect Disord. 2017 Oct 15;221:205-221. doi: 10.1016/j.jad.2017.06.034. Epub 2017 Jun 19.
6
Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.双相情感障碍的认知障碍:治疗和预防策略。
Int J Neuropsychopharmacol. 2017 Aug 1;20(8):670-680. doi: 10.1093/ijnp/pyx032.
7
Symptoms of Apathy Independently Predict Incident Frailty and Disability in Community-Dwelling Older Adults.冷漠症状可独立预测社区居住老年人发生衰弱和残疾的情况。
J Clin Psychiatry. 2017 May;78(5):e529-e536. doi: 10.4088/JCP.15m10113.
8
Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder.抗抑郁药物改善日常活动水平可预测重度抑郁症门诊患者的长期临床结局。
Neuropsychiatr Dis Treat. 2017 Mar 15;13:803-813. doi: 10.2147/NDT.S128407. eCollection 2017.
9
Mixed features in bipolar disorder.双相情感障碍中的混合特征。
CNS Spectr. 2017 Apr;22(2):134-140. doi: 10.1017/S1092852916000869. Epub 2016 Dec 29.
10
Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.选择性5-羟色胺再摄取抑制剂及5-羟色胺与去甲肾上腺素再摄取抑制剂可改善部分缓解型抑郁症患者的认知功能:一项前瞻性观察队列研究的结果
CNS Neurol Disord Drug Targets. 2016;15(10):1290-1298. doi: 10.2174/1871527315666161003170312.